Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MARS1 | P56192 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8112950 | 0.83 | ALDH1A1 (0.54) | ALDH1A1KMT2ATSHRLMNANPSR1 | |
| SCHEMBL4202205 | 0.81 | ALDH1A1 (0.51) | ALDH1A1TSHRLMNANPSR1KDM4E | |
| SCHEMBL4203255 | 0.81 | ALDH1A1 (0.49) | ALDH1A1KMT2ATSHRLMNANPSR1 | |
| SCHEMBL4205521 | 0.81 | ALDH1A1 (0.49) | ALDH1A1KMT2ATSHRNPSR1TP53 | |
| SCHEMBL12615992 | 0.80 | ALDH1A1 (0.68) | ALDH1A1KMT2ATSHRNPSR1KDM4E | |
| SCHEMBL28643711 | 0.80 | ALDH1A1 (0.53) | ALDH1A1KMT2ATSHRLMNAKDM4E | |
| SCHEMBL27941623 | 0.79 | ALDH1A1 (0.54) | ALDH1A1KMT2ATSHRNPSR1KDM4E | |
| SCHEMBL4210503 | 0.79 | ALDH1A1 (0.46) | ALDH1A1KMT2ATSHRNPSR1KDM4E | |
| SCHEMBL4197409 | 0.79 | XDH (0.48) | ALDH1A1KMT2ATSHRNPSR1NOTUM | |
| SCHEMBL2199051 | 0.78 | ALDH1A1 (0.49) | ALDH1A1KMT2ATSHRNPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1436317-A | Mixtures of organic silver salts in color photothermographic systems | EASTMAN KODAK CO (US) | 2003-08-13 | — | — | CN | claimed |
| US-9472717-B2 | Methods for making water soluble quantum dots | DREXEL UNIVERSITY (US) | 2016-10-18 | — | — | US | disclosed |
| US-20150311386-A1 | Methods for Making Water Soluble Quantum Dots | DREXEL UNIVERSITY (US) | 2015-10-29 | — | — | US | disclosed |
| US-9082918-B2 | Methods for making water soluble quantum dots | DREXEL UNIVERSITY (US) | 2015-07-14 | — | — | US | disclosed |
| US-20130207077-A1 | METHODS FOR MAKING WATER SOLUBLE QUANTUM DOTS | DREXEL UNIVERSITY (US) | 2013-08-15 | — | — | US | disclosed |
| US-8461316-B1 | Nanoparticles for delivery of bioactive agents | GP MEDICAL, INC. (US) | 2013-06-11 | — | — | US | disclosed |
| WO-2012054715-A2 | METHODS FOR MAKING WATER SOLUBLE QUANTUM DOTS | DREXEL UNIVERSITY (US) | 2012-04-26 | — | — | WO | disclosed |
| US-7579480-B2 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2009-08-25 | — | — | US | disclosed |
| CN-100402508-C | Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same | TOYO KASEI KOGYO CO LTD (JP) | 2008-07-16 | — | — | CN | disclosed |
| US-20070060630-A1 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO COMPANY LIMITED (JP) | 2007-03-15 | — | — | US | disclosed |
| CN-1826329-A | Alkoxy- (tetrazol-1-yl) benzaldehyde compound and process for producing the same | TOYO KASEI KOGYO CO LTD (JP) | 2006-08-30 | — | — | CN | disclosed |
| EP-1650198-A1 | ALKOXYTETRAZOL-1-YLBENZALDEHYDE COMPOUND AND PROCESS FOR PRODUCING THE SAME | Toyo Kasei Kogyo Company Limited (JP) | 2006-04-26 | — | — | EP | disclosed |
| CN-1436315-A | Packaged color photographic film capable of alternatively dry or wet-chemical processing | EASTMAN KODAK CO (US) | 2003-08-13 | — | — | CN | disclosed |
| CN-1436317-A | Mixtures of organic silver salts in color photothermographic systems | EASTMAN KODAK CO (US) | 2003-08-13 | — | — | CN | disclosed |
| CN-1436322-A | Dry thermal development including dual process compatible color photothermographic elements | EASTMAN KODAK CO (US) | 2003-08-13 | — | — | CN | disclosed |
| EP-1295173-A1 | PACKAGED COLOR PHOTOGRAPHIC FILM CAPABLE OF ALTERNATIVELY DRY OR WET-CHEMICAL PROCESSING | EASTMAN KODAK COMPANY (US) | 2003-03-26 | — | — | EP | disclosed |
| US-6497999-B1 | ORGANIC ADSORBATE THAT BLOCKS THE SURFACE OF THE ORGANIC SILVER SALT OR LIGAND TO IMPROVE RAW STOCK SPEED, STORAGE STABILITY; SPECTRAL SENSITIZING DYE | EASTMAN KODAK COMPANY | 2002-12-24 | — | — | US | disclosed |
| WO-2001096950-A1 | PACKAGED COLOR PHOTOGRAPHIC FILM CAPABLE OF ALTERNATIVELY DRY OR WET-CHEMICAL PROCESSING | EASTMAN KODAK COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060630-A1 | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same | ALDH7A1, NAT1, ARSA | ALDH1A1 4/4885KMT2A 303/4885TSHR 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.